Skip to content

Julie Rubinstein, President and COO at Adaptive Biotechnologies, sold ADPT on Oct 8, 2026

Data as of Oct 16

▼ SELL$305K11,881 shares at $25.66Julie Rubinstein President and COOADPT Adaptive Biotechnologies Corp
Watch ADPT
Traded
Oct 8, 2026
Disclosed
Oct 8, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Julie Rubinstein, President and COO at Adaptive Biotechnologies, sold ADPT on Oct 8, 2026TRADEDDISCLOSED
ADPTSimilar stocks (XLV — its sector index fund), rebased to ADPT's price on the disclosure day
ADPT since disclosure
−7.9%
after the sale
Similar stocks (XLV) since disclosure
+5.1%
XLV — its sector index fund

Change in closing price from Oct 8, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLJulie Rubinstein President and COOADPT Adaptive Biotechnologies Corp$314Kdisclosed Oct 8 · filed 1 day after the trade
  2. ▼ SELLJulie Rubinstein President and COOADPT Adaptive Biotechnologies Corp$15.2Kdisclosed Oct 8 · filed 2 days after the trade
  3. ▼ SELLJulie Rubinstein President and COOADPT Adaptive Biotechnologies Corp$31Kdisclosed Oct 8 · filed 2 days after the trade
  4. ▼ SELLJulie Rubinstein President and COOADPT Adaptive Biotechnologies Corp$257Kdisclosed Oct 8 · filed 2 days after the trade
  5. ▼ SELLJulie Rubinstein President and COOADPT Adaptive Biotechnologies Corp$26.8Kdisclosed Oct 8 · filed 2 days after the trade

See every trade on ADPT →